Random and site-specific radiolabeling of [89Zr]Zr-DFO-anti-PD-L1-mAb iPET tracer

Yi-Ching Lin,Chao-Wei Yang,Shih-Chuan Tsai,Shiou-Shiow Farn,Fang-Yu Ou Yang,Wei-Lin Lo,Liang-Cheng Chen,Kuo-Ting Chen,Mao-Chi Weng,Jui-Yin Kung,Xin-Yu Qiu,Ching-Chun Lu,Feng-Yun J. Huang

DOI: https://doi.org/10.1007/s10967-024-09401-0

2024-02-29

Journal of Radioanalytical and Nuclear Chemistry

Abstract:Zirconium-89 radiolabeled immuno-positron emission tomography ( 89 Zr-iPET) has become a critical tool for patient stratification before and after immunotherapies for therapeutic evaluation. In this study, random and site-specific radiolabeling of 89 Zr-iPET tracers were investigated. Traditional lysine-based conjugation and enzyme-based GlyCLICK ® kit method were used to prepare DFO-anti-PD-L1-mAb conjugates with a chelator-to-antibody ratio (CAR) of 0–7 and 2.0, respectively. Then, conjugates with different CAR levels were radiolabeled with 89 Zr to obtain randomly or site-specifically radiolabeled 89 Zr-iPET tracer.

chemistry, inorganic & nuclear, analytical,nuclear science & technology